serine/threonine Kinase 17b (STK17B) (C-Term) Peptide

Details for Product No. ABIN1382031
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Protein Name
Synonyms zgc:65989, STK17B, DRAK2, Drak2, 3110009A03Rik, AI120141
Protein Region
(1), (3), (1), (1)
Blocking Peptide (BP)
Pubmed 1 reference available
Quantity 0.05 mg
Shipping to United States ( )
Availability Will be delivered in 2 to 3 Business Days
Characteristics 15 amino acids near the carboxy terminus of human DRAK2.
Alternative Name DRAK2
Research Area Signaling, Apoptosis/Necrosis
Application Notes DRAK2 peptide is used for blocking the activity of DRAK2.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Sanjo, Kawai, Akira: "DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis." in: The Journal of biological chemistry, Vol. 273, Issue 44, pp. 29066-71, 1998 (PubMed).

Catalog No. ABIN1382031
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)